Company Legal Name
Latest Valuation
Founded Year
Headquarter
Function Health operates a telehealth platform that delivers personalized health insights through comprehensive blood test analysis and genetic testing directly to consumers. The San Francisco-based company distinguishes itself by making advanced diagnostic testing accessible outside traditional healthcare systems, enabling individuals to proactively monitor their health metrics. Since its 2023 founding, Function Health has achieved rapid market traction, securing a $2.5 billion valuation that positions it among the most valuable early-stage healthtech companies. The company continues expanding its diagnostic capabilities and data analytics platform to serve the growing consumer demand for personalized, preventive healthcare solutions.
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.
